Skip to main content
. 2023 Jul 27;11(8):2123. doi: 10.3390/biomedicines11082123

Table 1.

COVID-19 affects immune response and development of tuberculosis infection.

TB Infection and COVID-19 Immune Response First Author, Year of Publication
LTBI + COVID-19 (clinical case) decline in CD4+ T cell count along with latent-to-active TB progression Khayat M, 2021 [24]
LTBI + COVID-19 (study data) LTBI with COVID-19 showed significantly higher plasma levels of IFN γ, IL-2, TNF α, IL- 1 α, IL-1 β, IL-6, IL-12, IL-15, IL-17, IL-3, GM-CSF, IL-10, IL-25, IL-33, CCL3 and CXCL10 Rajamanickam A, 2021 [25]
LTBI + COVID-19 (review) decreased cytokine levels shown for IL-2, IL-4, IL-5 and IL-13 Shariq M, 2022 [26]
LTBI + COVID-19
(study data)
LTBI in COVID subjects had lowered CD8+ T cell count and IFN-γ level Palacios-Gutiérrez JJ, 2022 [27]
TB +COVID-19
(study data)
low level of IFN-γ in COVID-19 and TB patients Petrone L, 2021 [28]
TB +COVID-19
(study data)
decreased SARS-CoV-2-specific CD4 T cell level in COVID-19 and TB patients Flores-Lovon K, 2022 [29]